NCT02441062
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +14 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
Clinical trial condition
Neuroectodermal Tumors, Primitive
Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.
727 public trials
122 recruiting studies
Neuroectodermal Tumors, Primitive trial results
NCT00880308
- Conditions
- Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
- Locations
-
- University of Pittsburgh Medical Center SC Pittsburgh, Pennsylvania, United States
- Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5) San Antonio, Texas, United States
- Novartis Investigative Site Barcelona, Catalonia, Spain
- Novartis Investigative Site Zurich, Switzerland
Completed
An East Asian Study of LDE225
NCT01208831
- Conditions
- Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
- Locations
-
- Novartis Investigative Site Hong Kong
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
- Novartis Investigative Site Taipei, Taiwan
NCT01106508
- Conditions
- Advanced Solid Tumors, Carcinoma, Carcinoma, Basal Cell, +17 more
- Locations
-
- University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Novartis Investigative Site Utrecht, Netherlands
- Novartis Investigative Site Zurich, Switzerland
NCT04300179
- Conditions
- Bone Diseases, Bone Neoplasms, Musculoskeletal Diseases, +17 more
- Locations
-
- South Egypt Cancer Institute Asyut, Egypt
Completed
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
NCT02159443
- Conditions
- Ewing Family of Tumors, Melanoma, Neoplasms, +20 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Completed
ch14.18/CHO Bridging Study
NCT01704872
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- St Anna Kinderspital Vienna, Austria
- Charite Children's Hospital Berlin, Germany
- Gaslini Children's Hospital Genova, Italy
NCT00026780
- Conditions
- Acute Lymphoblastic Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +38 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
NCT01467986
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
- Locations
-
- University Hospital Regensburg, Department of Pediatric Hematology and Oncology Regensburg, Germany
NCT02271711
- Conditions
- Ependymoma, Glioma, Medulloblastoma, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States